{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,9]],"date-time":"2026-03-09T00:05:48Z","timestamp":1773014748766,"version":"3.50.1"},"reference-count":44,"publisher":"Oxford University Press (OUP)","issue":"3","license":[{"start":{"date-parts":[[2021,6,21]],"date-time":"2021-06-21T00:00:00Z","timestamp":1624233600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/journals\/pages\/open_access\/funder_policies\/chorus\/standard_publication_model"}],"funder":[{"name":"National Institute of Health\/National Institute of Arthritis and Musculoskeletal and Skin Diseases","award":["R01AR072695"],"award-info":[{"award-number":["R01AR072695"]}]},{"name":"Scleroderma Clinical Trials Consortium"},{"name":"National Research, Development and Innovation Office of Hungary","award":["127957\u2009127933"],"award-info":[{"award-number":["127957\u2009127933"]}]},{"DOI":"10.13039\/501100000780","name":"European Union","doi-asserted-by":"publisher","award":["GINOP-2.3.2-15-2016-00015"],"award-info":[{"award-number":["GINOP-2.3.2-15-2016-00015"]}],"id":[{"id":"10.13039\/501100000780","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"NIH","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2022,3,2]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:sec>\n                  <jats:title>Objective<\/jats:title>\n                  <jats:p>The pathogenesis of calcinosis cutis, a disabling complication of SSc, is poorly understood and effective treatments are lacking. Inorganic pyrophosphate (PPi) is a key regulator of ectopic mineralization, and its deficiency has been implicated in ectopic mineralization disorders. We therefore sought to test the hypothesis that SSc may be associated with reduced circulating PPi, which might play a pathogenic role in calcinosis cutis.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Methods<\/jats:title>\n                  <jats:p>Subjects with SSc and age-matched controls without SSc were recruited from the outpatient rheumatology clinics at Rutgers and Northwestern Universities (US cohort), and from the Universities of Szeged and Debrecen (Hungarian cohort). Calcinosis cutis was confirmed by direct palpation, by imaging or both. Plasma PPi levels were determined in platelet-free plasma using ATP sulfurylase to convert PPi into ATP in the presence of excess adenosine 5\u2019 phosphosulfate.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Results<\/jats:title>\n                  <jats:p>Eighty-one patients with SSc (40 diffuse cutaneous, and 41 limited cutaneous SSc) in the US cohort and 45 patients with SSc (19 diffuse cutaneous and 26 limited cutaneous SSc) in the Hungarian cohort were enrolled. Calcinosis was frequently detected (40% of US and 46% of the Hungarian cohort). Plasma PPi levels were significantly reduced in both SSc cohorts with and without calcinosis (US: P\u2009=\u20090.003; Hungarian: P\u2009&amp;lt;\u20090.001).<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Conclusions<\/jats:title>\n                  <jats:p>Circulating PPi are significantly reduced in SSc patients with or without calcinosis. Reduced PPi may be important in the pathophysiology of calcinosis and contribute to tissue damage with chronic SSc. Administering PPi may be a therapeutic strategy and larger clinical studies are planned to confirm our findings.<\/jats:p>\n               <\/jats:sec>","DOI":"10.1093\/rheumatology\/keab508","type":"journal-article","created":{"date-parts":[[2021,6,18]],"date-time":"2021-06-18T11:09:09Z","timestamp":1624014549000},"page":"1158-1165","source":"Crossref","is-referenced-by-count":13,"title":["Inorganic pyrophosphate is reduced in patients with systemic sclerosis"],"prefix":"10.1093","volume":"61","author":[{"given":"Vivien M","family":"Hsu","sequence":"first","affiliation":[{"name":"Rheumatology Division, Department of Medicine, Rutgers-RWJ Medical School, New Brunswick, NJ, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eszter","family":"Koz\u00e1k","sequence":"additional","affiliation":[{"name":"Institute of Enzymology, Research Center for Natural Sciences, Hungarian Academy of Sciences Centre of Excellence, Budapest, Hungary"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Qiaoli","family":"Li","sequence":"additional","affiliation":[{"name":"The Sidney Kimmel Medical College, The PXE International Center of Excellence in Research and Clinical Care, and Jefferson Institute of Molecular Medicine, Thomas Jefferson University, Philadelphia, PA, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M\u00e1rta","family":"Bocskai","sequence":"additional","affiliation":[{"name":"Department of Rheumatology and Immunology, University of Szeged, Szeged, Hungary"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Naomi","family":"Schlesinger","sequence":"additional","affiliation":[{"name":"Rheumatology Division, Department of Medicine, Rutgers-RWJ Medical School, New Brunswick, NJ, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ann","family":"Rosenthal","sequence":"additional","affiliation":[{"name":"Rheumatology Division, Department of Medicine, Medical College of Wisconsin, Milwaukee, WI"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Scott T","family":"McClure","sequence":"additional","affiliation":[{"name":"Department of Statistics, Shenandoah University, Winchester, VA"},{"name":"Rebel Analytics, LLC, Laguna Hills, CA, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"L\u00e1szl\u00f3","family":"Kov\u00e1cs","sequence":"additional","affiliation":[{"name":"Department of Rheumatology and Immunology, University of Szeged, Szeged, Hungary"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"L\u00e1szl\u00f3","family":"B\u00e1lint","sequence":"additional","affiliation":[{"name":"Genomic Medicine and Bioinformatic Core Facility, Department of Biochemistry and Molecular Biology, University of Debrecen, Hungary University of Szeged, Szeged"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Szilvia","family":"Szamosi","sequence":"additional","affiliation":[{"name":"Division of Rheumatology, University of Debrecen, Debrecen, Hungary"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gabriella","family":"Sz\u00fccs","sequence":"additional","affiliation":[{"name":"Division of Rheumatology, University of Debrecen, Debrecen, Hungary"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mary","family":"Carns","sequence":"additional","affiliation":[{"name":"Divisions of Rheumatology and Pulmonary and Critical Care Medicine, Department of Medicine, Northwestern University, Chicago, IL"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kathleen","family":"Aren","sequence":"additional","affiliation":[{"name":"Divisions of Rheumatology and Pulmonary and Critical Care Medicine, Department of Medicine, Northwestern University, Chicago, IL"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7178-9729","authenticated-orcid":false,"given":"Isaac","family":"Goldberg","sequence":"additional","affiliation":[{"name":"Divisions of Rheumatology and Pulmonary and Critical Care Medicine, Department of Medicine, Northwestern University, Chicago, IL"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andr\u00e1s","family":"V\u00e1radi","sequence":"additional","affiliation":[{"name":"Institute of Enzymology, Research Center for Natural Sciences, Hungarian Academy of Sciences Centre of Excellence, Budapest, Hungary"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"John","family":"Varga","sequence":"additional","affiliation":[{"name":"Divisions of Rheumatology and Pulmonary and Critical Care Medicine, Department of Medicine, Northwestern University, Chicago, IL"},{"name":"Rheumatology Division, Department of Medicine, University of Michigan, Ann Arbor, MI, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","published-online":{"date-parts":[[2021,6,21]]},"reference":[{"key":"2022052114462011600_keab508-B1","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1016\/S0002-9440(10)65313-8","article-title":"Ectopic mineralization: gathering hard facts about soft tissue mineralization","volume":"154","author":"Giachelli","year":"1999","journal-title":"Am J Pathol"},{"key":"2022052114462011600_keab508-B2","doi-asserted-by":"crossref","first-page":"1860","DOI":"10.1016\/j.jacc.2006.10.079","article-title":"Long-term prognosis associated with coronary mineralization: observations from a registry of 25,253 patients","volume":"49","author":"Budoff","year":"2007","journal-title":"J Am Coll Cardiol"},{"key":"2022052114462011600_keab508-B3","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1002\/art.1780270202","article-title":"Clinical and laboratory associations of anticentromere antibody in patients with progressive systemic sclerosis","volume":"27","author":"Steen","year":"1984","journal-title":"Arthritis Rheum"},{"key":"2022052114462011600_keab508-B4","first-page":"303","article-title":"Calcinosis in poly-dermatomyositis: clinical and laboratory predictors and treatment options","volume":"35","author":"Fredi","year":"2017","journal-title":"Clin Exp Rheumatol"},{"key":"2022052114462011600_keab508-B5","first-page":"427","article-title":"The calcium invasion: calciphylaxis in lupus","volume":"65","author":"Nazir","year":"2015","journal-title":"J Pak Med Assoc"},{"key":"2022052114462011600_keab508-B6","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1097\/BOR.0000000000000477","article-title":"Basic calcium phosphate crystal-associated musculoskeletal syndromes: an update","volume":"30","author":"Rosenthal","year":"2018","journal-title":"Curr Opin Rheumatol"},{"key":"2022052114462011600_keab508-B7","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1039\/b716791a","article-title":"Detection of calcium phosphate crystals in the joint fluid of patients with osteoarthritis\u2014analytical approaches and challenges","volume":"133","author":"Yavorskyy","year":"2008","journal-title":"Analyst"},{"key":"2022052114462011600_keab508-B8","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1186\/s13075-017-1225-0","article-title":"Osteoarthritis-associated basic calcium phosphate crystals activate membrane proximal kinases in human innate immune cells","volume":"19","author":"Corr","year":"2017","journal-title":"Arthritis Res Ther"},{"key":"2022052114462011600_keab508-B9","first-page":"73","article-title":"Calcinosis in systemic sclerosis: update in pathophysiology, evaluation and treatment","volume":"22","author":"Richardson","year":"2020","journal-title":"Curr Opin Rheumatol"},{"key":"2022052114462011600_keab508-B10","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1097\/BOR.0000000000000658","article-title":"Calcinosis in scleroderma made crystal clear","volume":"31","author":"Hsu","year":"2019","journal-title":"Curr Opin Rheumatol"},{"key":"2022052114462011600_keab508-B11","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1016\/j.tcm.2012.07.011","article-title":"Genetics in arterial mineralization: lessons learned from rare diseases","volume":"22","author":"Nitschke","year":"2012","journal-title":"Trends Cardiovasc Med"},{"key":"2022052114462011600_keab508-B12","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/j.ajpath.2013.03.002","article-title":"Mineralization\/anti-mineralization networks in the skin and vascular connective tissues","volume":"183","author":"Li","year":"2013","journal-title":"Am J Pathol"},{"key":"2022052114462011600_keab508-B13","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1016\/j.jid.2015.10.065","article-title":"Research progress in pseudoxanthoma elasticum and related ectopic mineralization disorders","volume":"136","author":"Li","year":"2016","journal-title":"J Invest Dermatol"},{"key":"2022052114462011600_keab508-B14","first-page":"298","article-title":"Cardiovascular manifestations of pseudoxanthoma elasticum","volume":"102","author":"Mendelsohn","year":"1978","journal-title":"Arch Pathol Lab Med"},{"key":"2022052114462011600_keab508-B15","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1016\/j.ajpath.2018.09.014","article-title":"Pseudoxanthoma elasticum as a paradigm of heritable ectopic mineralization disorders: patho-mechanisms and treatment development","volume":"189","author":"Li","year":"2019","journal-title":"Am J Pathol"},{"key":"2022052114462011600_keab508-B16","doi-asserted-by":"crossref","first-page":"901","DOI":"10.1038\/212901a0","article-title":"Effect of pyrophosphate on hydroxyapatite and its implications in calcium homeostasis","volume":"212","author":"Fleisch","year":"1966","journal-title":"Nature"},{"key":"2022052114462011600_keab508-B17","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/j.coph.2016.03.003","article-title":"Pyrophosphate: a key inhibitor of mineralisation","volume":"28","author":"Orriss","year":"2016","journal-title":"Curr Opin Pharmacol"},{"key":"2022052114462011600_keab508-B18","doi-asserted-by":"crossref","first-page":"1747","DOI":"10.1136\/annrheumdis-2013-204424","article-title":"Classification criteria for systemic sclerosis: an American College of Rheumatology\/European League Against Rheumatism collaborative initiative","volume":"72","author":"van den Hoogen","year":"2013","journal-title":"Ann Rheum Dis"},{"key":"2022052114462011600_keab508-B19","doi-asserted-by":"crossref","first-page":"2569","DOI":"10.1002\/art.27584","article-title":"2010 Rheumatoid arthritis classification criteria: an American College of Rheumatology\/European League Against Rheumatism collaborative initiative","volume":"62","author":"Aletaha","year":"2010","journal-title":"Arthritis Rheum"},{"key":"2022052114462011600_keab508-B20","doi-asserted-by":"crossref","first-page":"680","DOI":"10.1016\/j.mayocp.2015.03.014","article-title":"Fibromyalgia and related conditions","volume":"90","author":"Clauw","year":"2015","journal-title":"Mayo Clin Proc"},{"key":"2022052114462011600_keab508-B21","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1016\/j.semarthrit.2013.12.007","article-title":"Generalized osteoarthritis: a systematic review","volume":"43","author":"Nelson","year":"2014","journal-title":"Semin Arthritis Rheum"},{"key":"2022052114462011600_keab508-B22","doi-asserted-by":"crossref","first-page":"1025","DOI":"10.1016\/j.jid.2016.11.042","article-title":"Abcc6 knockout rat model highlights the role of liver in PPi homeostasis in pseudoxanthoma elasticum","volume":"137","author":"Li","year":"2017","journal-title":"J Invest Dermatol"},{"key":"2022052114462011600_keab508-B23","doi-asserted-by":"crossref","first-page":"1985","DOI":"10.1161\/ATVBAHA.114.304017","article-title":"ABCC6-mediated ATP secretion by the liver is the main source of the mineralization inhibitor inorganic pyrophosphate in the systemic circulation-brief report","volume":"34","author":"Jansen","year":"2014","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"2022052114462011600_keab508-B24","first-page":"1129","article-title":"Using a filtration technique to isolate platelet free plasma for assaying pyrophosphate","volume":"58","author":"Tolouian","year":"2012","journal-title":"Clin Lab"},{"key":"2022052114462011600_keab508-B25","doi-asserted-by":"crossref","first-page":"2609","DOI":"10.4161\/15384101.2014.943567","article-title":"Juxta-articular joint-capsule mineralization in Cd73 deficient mice: similarities to patients with NT5E mutations","volume":"13","author":"Li","year":"2014","journal-title":"Cell Cycle"},{"key":"2022052114462011600_keab508-B26","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/0003-2697(77)90510-3","article-title":"Analysis of inorganic pyrophosphate at the picomole level","volume":"83","author":"Cheung","year":"1977","journal-title":"Anal Biochem"},{"key":"2022052114462011600_keab508-B27","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1093\/ndt\/gfp362","article-title":"Plasma pyrophosphate and vascular calcification in chronic kidney disease","volume":"25","author":"O'Neill","year":"2010","journal-title":"Nephrol Dial Transplant"},{"key":"2022052114462011600_keab508-B28","doi-asserted-by":"crossref","first-page":"1463","DOI":"10.15252\/emmm.201707532","article-title":"Oral administration of pyrophosphate inhibits connective tissue calcification","volume":"9","author":"Dedinszki","year":"2017","journal-title":"EMBO Mol Med"},{"key":"2022052114462011600_keab508-B29","doi-asserted-by":"crossref","first-page":"1557","DOI":"10.1007\/s10067-015-2998-7","article-title":"Use of dual energy computed tomography for the evaluation of calcinosis in patients with systemic sclerosis","volume":"34","author":"Hsu","year":"2015","journal-title":"Clinical Rheumatology"},{"key":"2022052114462011600_keab508-B30","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1080\/03009742.2016.1219766","article-title":"X-ray diffraction analysis of spontaneously draining calcinosis from scleroderma patients","volume":"46","author":"Hsu","year":"2017","journal-title":"Scand J Rheumatol"},{"key":"2022052114462011600_keab508-B31","doi-asserted-by":"crossref","first-page":"542","DOI":"10.1097\/BOR.0000000000000220","article-title":"Calcinosis: pathophysiology and management","volume":"27","author":"Valenzuela","year":"2015","journal-title":"Curr Opin Rheumatol"},{"key":"2022052114462011600_keab508-B32","doi-asserted-by":"crossref","first-page":"876","DOI":"10.1093\/rheumatology\/kep151","article-title":"Expression of advanced glycation end products and their receptor in skin from patients with systemic sclerosis with and without calcinosis","volume":"48","author":"Davies","year":"2009","journal-title":"Rheumatology"},{"key":"2022052114462011600_keab508-B33","doi-asserted-by":"crossref","first-page":"e0180098","DOI":"10.1371\/journal.pone.0180098","article-title":"Intraperitoneal pyrophosphate treatment reduces renal calcifications in Npt2a null mice","volume":"12","author":"Caballero","year":"2017","journal-title":"PLoS One"},{"key":"2022052114462011600_keab508-B34","first-page":"387","article-title":"The role of inorganic pyrophosphate in aortic valve calcification","volume":"23","author":"Rathan","year":"2014","journal-title":"J Heart Valve Dis"},{"key":"2022052114462011600_keab508-B35","doi-asserted-by":"crossref","first-page":"568","DOI":"10.1016\/j.atherosclerosis.2014.10.027","article-title":"Extracellular pyrophosphate is reduced in aortic interstitial valve cells acquiring a calcifying profile: implications for aortic valve calcification","volume":"237","author":"Rattazzi","year":"2014","journal-title":"Atherosclerosis"},{"key":"2022052114462011600_keab508-B36","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1093\/cvr\/cvs187","article-title":"Mechanisms of ATP release and signaling in the blood vessel wall","volume":"95","author":"Lohman","year":"2012","journal-title":"Cardiovasc Res"},{"key":"2022052114462011600_keab508-B37","doi-asserted-by":"crossref","first-page":"20206","DOI":"10.1073\/pnas.1319582110","article-title":"ABCD6 prevents ectopic mineralization seen in pseudoxanthoma elasticum by inducing cellular nucleotide release","volume":"110","author":"Jansen","year":"2013","journal-title":"Proc Natl Acad Sci USA"},{"key":"2022052114462011600_keab508-B38","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1016\/j.clinbiochem.2014.07.003","article-title":"Variants in genes encoding pyrophosphate metabolizing enzymes are associated with pseudoxanthoma elasticum","volume":"47","author":"Dabisch-Ruthe","year":"2014","journal-title":"Clin Bichem"},{"key":"2022052114462011600_keab508-B39","doi-asserted-by":"crossref","first-page":"e1008884","DOI":"10.1371\/journal.pgen.1008884","article-title":"The membrane protein ANKH is crucial for bone mechanical performance by mediating cellular export of citrate and ATP","volume":"16","author":"Szeri","year":"2020","journal-title":"PLoS Genet"},{"key":"2022052114462011600_keab508-B40","article-title":"Low nucleoside triphosphate pyrophosphohydrolase activity contributes to pathologic mineralization in systemic sclerosis [abstract #841]","volume":"68","author":"Ding","year":"2016","journal-title":"Arthritis Rheumatol"},{"key":"2022052114462011600_keab508-B41","doi-asserted-by":"crossref","first-page":"849","DOI":"10.1093\/rheumatology\/keaa332","article-title":"High proton pump inhibitor exposure increases risk of calcinosis in systemic sclerosis","volume":"60","author":"Host","year":"2021","journal-title":"Rheumatology"},{"key":"2022052114462011600_keab508-B42","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1007\/s11926-018-0712-x","article-title":"Targeting senescent cells in fibrosis: pathology, paradox, and practical considerations","volume":"20","author":"Schafer","year":"2018","journal-title":"Curr Rheumatol Rep"},{"key":"2022052114462011600_keab508-B43","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1007\/s11926-020-00920-9","article-title":"Mitochondria, aging and cellular senescence: implications for scleroderma","volume":"22","author":"Bueno","year":"2020","journal-title":"Curr Rheumatol Rep"},{"key":"2022052114462011600_keab508-B44","doi-asserted-by":"crossref","first-page":"1361","DOI":"10.1002\/art.41267","article-title":"Pathogenic activation of mesenchymal stem cells is induced by the disease microenvironment in systemic sclerosis","volume":"72","author":"Taki","year":"2020","journal-title":"Arthritis Rheumatol"}],"container-title":["Rheumatology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/rheumatology\/advance-article-pdf\/doi\/10.1093\/rheumatology\/keab508\/39309873\/keab508.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/rheumatology\/article-pdf\/61\/3\/1158\/43780287\/keab508.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/rheumatology\/article-pdf\/61\/3\/1158\/43780287\/keab508.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,5,21]],"date-time":"2022-05-21T14:46:58Z","timestamp":1653144418000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/rheumatology\/article\/61\/3\/1158\/6307277"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,6,21]]},"references-count":44,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2021,6,21]]},"published-print":{"date-parts":[[2022,3,2]]}},"URL":"https:\/\/doi.org\/10.1093\/rheumatology\/keab508","relation":{},"ISSN":["1462-0324","1462-0332"],"issn-type":[{"value":"1462-0324","type":"print"},{"value":"1462-0332","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2022,3,1]]},"published":{"date-parts":[[2021,6,21]]}}}